Hexane Fraction of Zingiberis Rhizoma Crudus Extract Inhibits the Production of Nitric Oxide and Pro-inflammatory Cytokines in LPS-stimulated BV2 Microglial Cells

뇌신경소교세포(腦神經小膠細胞)에서 생강 헥산 분획물의 염증매개물질 생성(生成) 억제효과(抑制效果)

  • Jung, Hwan-Yong (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Dongguk University) ;
  • Joo, Ye-Jin (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Dongguk University) ;
  • Jung, Hye-Mi (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Dongguk University) ;
  • Shin, Woo-Jin (Samse Oriental Medical Hospital) ;
  • Seo, Un-Kyo (Dept. of Oriental Internal Medicine, College of Oriental Medicine, Dongguk University)
  • 정환용 (동국대학교 한의과대학 내과학교실) ;
  • 주예진 (동국대학교 한의과대학 내과학교실) ;
  • 정혜미 (동국대학교 한의과대학 내과학교실) ;
  • 신우진 (삼세한방병원 내과) ;
  • 서운교 (동국대학교 한의과대학 내과학교실)
  • Published : 2009.03.31

Abstract

Objectives: The present study is focused on the inhibitory effect of the rhizome hexane fraction extract of Zingiberis Rhizoma Crudus (ginger hexan extract; GHE) on the production of inflammatory mediators such as NO, $PGE_2$, and proinflammatory cytokines in lipopolysaccharide (LPS)-stimulated BV2 cells, a mouse microglial cell line. Methods: We separated the hexane fraction from Zingiberis Rhizoma Crudus's methanol extract. The inhibitory and anti-inflammatory effect of GHE was examined on microglial activation. Results: GHE significantly inhibited the excessive production of NO, $PGE_2$, TNF-${\alpha}$, and IL-1${\beta}$ in LPS-stimulated BV2 cells. In addition, GHE attenuated the mRNA expressions and protein levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and proinflammatory cytokines. Conclusion: The anti-inflammatory properties of GHE may make it useful as a therapeutic candidate for the treatment of human neurodegenerative diseases.

Keywords

References

  1. Orr CF, Rowe DB, Haliday GM. An inflammatory review of Parkinson's disease. Progress in neurobiology. 2002;68:325-40. https://doi.org/10.1016/S0301-0082(02)00127-2
  2. Norton WT, Aquino DA, Hozymi I, Chiu FC, Brosnan CF. Quantative aspects of reactive gliosis: a review. Neurochemical research. 1992; 17:877-85. https://doi.org/10.1007/BF00993263
  3. Vila M, Jackson-Lewis V, Guegan C, Wu DC, Teismann P, Choi DK, Tieu K, Prezeborski S. The role of glial cells in Parkinson's disease. Current opinion in neurology. 2001;14:483-9. https://doi.org/10.1097/00019052-200108000-00009
  4. Gonzalez-Scarano F, Baultuch G. Microglia as mediators of inflammatory and degenerative disease. Annual review of neuroscience 1999;34: 307-21.
  5. Cross AK, Woodroofe MN. Immunoregulation of microglial functional properties. Microscopy research and technique. 2001;54:10-7. https://doi.org/10.1002/jemt.1115
  6. Seo WG, Pae HO, Oh GS, Chai KY, Kwon TO, Yun YG, Kim NY, Chung HT. Inhibitory effects of methanol extract of Cyperus rotundus rhizomes on nitric oxide and superoxide productions by murine macrophage cell line, RAW264.7 cells. Journal of ethnopharmacology. 2001;76:59-64. https://doi.org/10.1016/S0378-8741(01)00221-5
  7. 上海科學技術出版社. 小學的綿, 中藥大辭典, 第 11卷. 東京:(株)小學館. 1985: 1207 .
  8. 한의과대학 본초학편찬위원회. 본초학. 서울:영림사. 2007:375-7.
  9. 李時珍.本草綱目. 北京:人民衛生出版社. 1982: 1620-5.
  10. Al-Yahya MA, Rafatullah S, Mossa JS, Ageel AM, Parmar NS, Tariq M. Gastroprotective activity of ginger zingiber officinale rosc, in albino rats. The American journal of Chinese medicine. 1989;17(1-2):51-6. https://doi.org/10.1142/S0192415X89000097
  11. Holtmann S, Clarke AH, Scherer H, H hn H. The antimotion sickness mechanizm of ginger. Acta oto-laryngologica. 1989;108:168-14. https://doi.org/10.3109/00016488909125515
  12. Bone ME, Wilkinson DJ, Young JR, McNeil J, Charlton S. Ginger root-a new antiemetic, The effect of ginger root on postoperative nausea and vomiting after major gynaccological surgery. Anaesthesia. 1990;45:669-71. https://doi.org/10.1111/j.1365-2044.1990.tb14395.x
  13. Sharma SS, Kochupillai V, Gupta SK, Seth SD, Gupta YK. Antiemetic efficacy of ginger(Zingiber officinale) against cisplatin-induced emesis in dogs. Journal of Ethnopharmacology. 1997;57: 93-6. https://doi.org/10.1016/S0378-8741(97)00054-8
  14. Chung YK. Components of essential oil and antimicrobial of ginger. Journal of Korean Society Applied Biological Chemistry. 1997;40(6):514-8.
  15. F Zakaria-Rungkat, Nurahman, E Prangdimurt, Tejasari. Antioxidant and Immunoenhancement Activities of Ginger (Zingiber officinale Roscoe) Extracts and Compounds in In Vitro and In Vivo Mouse and Human System. Nutraceuticals & Food 2003;8(1):96-104. https://doi.org/10.3746/jfn.2003.8.1.096
  16. Lee BS, Ko MS, Kim HJ, Kim DH. Seperation of 6-gingerol from ginger and antioxidative activity. Korean Journal of Biotechnology and bioengineering. 2006;21:484-8.
  17. Park KK, KS Chun, JM Lee, SS Lee, YJ Surh. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer letters. 1988;129:139-44. https://doi.org/10.1016/S0304-3835(98)00081-0
  18. Eguchi A, Murakami A, Ohigashi H. Novel bioassay system for evaluating anti-oxidative activities of food items: use of basolateral media from differentiated Caco-2 cells. Free Radical Research 2005;39:1367-75. https://doi.org/10.1080/10715760500045624
  19. Lantz RC, Chen GJ, Sarihan M, Sólyom AM, Jolad SD, Timmermann BN. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine. 2007;14: 123-8. https://doi.org/10.1016/j.phymed.2006.03.003
  20. Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG. Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. Journal of alternative and complementary medicine. 2004;10(6):1009-13. https://doi.org/10.1089/acm.2004.10.1009
  21. McGeer PL, Yasojima K, McGeer EG. Inflammation in Parkinson's disease. Advances in neurology. 2001;86:83-93.
  22. Hunot S, Dugas B, Faucheux B, Hartmann A, Tardieu M, Debre P, Agid Y, Dugas B, Hirasch EC. FceRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-a in glial cells. The Journal of neuroscience. 1999;19:3440-7.
  23. Gonzalez-Scarano F, Baultuch G. Microglia as mediators of inflammatory and degenerative disease. Annual review of neuroscience. 1999;34:307-21.
  24. Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine & growth factor reviews. 2002;3(4-5):413-21.
  25. 黃宮繡. 本草求真. 台北:宏業吉間有限公司. 1981: 75-6.
  26. Qureshi S, Shah AH, Tariq M, Ageel AM. Studies on herbal aphrodisiacs used in Arab system of medicine. The American journal of Chinese medicine. 1989;17(1-2):57-63. https://doi.org/10.1142/S0192415X89000103
  27. Suekawa M, Ishige A, Yuasa K, Sudo M, Aburada M, Hosoya E. Pharmacological Studies on ginger I, Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. Journal of pharmacobio-dynamics. 1984;7:836-48. https://doi.org/10.1248/bpb1978.7.836
  28. Nakamura H, Yamamoto T. The active part of the [6]-gingerol molecule in mutagenesis. Mutation research. 1983;122(2):87-94. https://doi.org/10.1016/0165-7992(83)90043-X
  29. Park KY, Lee SJ, Lee KI, Rhee SH. The antitumor effect in sarcoma-180 tumor cell of mice administered with Japannes apricot, garlic or ginger Doenjang. Korean Journal of Food and Cookery Science. 2006;5(21):599-606.
  30. Shoji N, Iwasa A, Takemoto T, Ishida Y, Ohizumi Y. Cardiotonic principles of ginger(Zingiber officinale Rosc.). Journal of pharmaceutical sciences. 1982;71:1174. https://doi.org/10.1002/jps.2600711025
  31. Lee YL, Shih K, Bao P, Ghirnikar RS, Eng LF. Cytokine chemokine expression in contused rat spinal cord. Neurochemistry international. 2000; 36(4-5):417-25. https://doi.org/10.1016/S0197-0186(99)00133-3
  32. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cellular Signaling. 2001;13:85-94. https://doi.org/10.1016/S0898-6568(00)00149-2